• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: Bioartificial liver system utilizing encapsulated human Hep G2 hepatoblastoma cells in a fluidised bed bioreactor (BAL).
Date Designated: 09/09/2020
Orphan Designation: Treatment of Acute Liver failure.
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
ESPL Regulatory Consulting Limited
25 Bank Place
Blackpool Retail Park, Blackpool, Co. Cork
Mallow, Cork
Ireland

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-